Cynata Therapeutics Ltd has released a press release.
March 2017 Quarterly Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Cynata Advances to Pre-IND Meeting with US FDA
- CYP Files for New Patent for Oncology Applications
- CYP in Collaboration on Acute Respiratory Distress Syndrome
- Cynata Partner apceth GmbH & Co Completes Cymerus Evaluation
- CYP Advances Development of Cymerus for Treatment of Asthma
Later from Cynata Therapeutics
- Treatment Commences in Cynatas World First Clinical Trial
- United States Patent for Core Cynata Technology
- Cynata Files New Patent Application for Cymerus in Oncology
- CYP MSC Data in Asthma Model Published in Sceintific Journal
- Cynata Therapeutics GvHD Clinical Trial & Corporate Progress
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics